Naveris

Waltham, United States

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

$17.5M raised

Jul 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Naveris raised?

Naveris has raised $17.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.

Who are Naveris's investors?

Naveris's investors include Gurnet Point Capital, TechU Ventures, BrightEdge Fund, Sky Ventures Group, R-Cubed Capital Partners.

Where is Naveris headquartered?

Naveris is headquartered in Waltham, United States.

What does Naveris do?

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

What stage is Naveris at?

Naveris is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 2, 2024.

MLA

"Naveris — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/naveris. Accessed July 2, 2026.

APA

VCBacked. (2024). Naveris — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/naveris

Wikipedia (cite web)

{{cite web |title=Naveris — Funding & Investors |url=https://www.vcbacked.co/company/naveris |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 2, 2024.